Gilead Sciences (GILD) FCF Margin (2009 - 2026)

Gilead Sciences (GILD) has reported FCF Margin for 18 consecutive years, with 44.0% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, FCF Margin rose 3383.0% year-over-year to 44.0%; the trailing twelve-month figure through Jun 2026 stood at 42.5% (up 1004.0% YoY), and the FY2025 full-year result was 32.12%, down 372.0% from the prior year.
• FCF Margin rose to 44.0% in Q2 2026 per GILD's latest filing, from 34.87% in the prior quarter.
• Across five years, FCF Margin topped out at 55.24% in Q3 2024 and bottomed at 10.17% in Q2 2025.
• Historically, FCF Margin has averaged 32.04% across 5 years, with a median of 31.95% in 2022.
• The sharpest annual moves came in 2024 and 2026: FCF Margin tumbled 1614 bps in 2024, then jumped 3383 bps in 2026.
• Over 5 years, FCF Margin stood at 32.29% in 2022, then fell by 15 bps to 27.47% in 2023, then jumped by 36 bps to 37.36% in 2024, then grew by 5 bps to 39.39% in 2025, then grew by 12 bps to 44.0% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 44.0%, 34.87%, and 39.39% for Q2 2026, Q1 2026, and Q4 2025 respectively.